Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced multiple clinical research results to be presented at the 2025 American Society of Clinical ...

The rise of GLP-1 agonist therapies has transformed obesity treatment, delivering unprecedented results and revealing their ...

The global human liver model market was valued at USD 1.19 billion in 2023 and is projected to expand at a robust CAGR of 13.8% from 2024 to 2030, culminating in a market size of USD 3.19 billion by ...

Generation Mining Limited ("Gen Mining" or the "Company") is pleased to announce receipt of a support letter from a leading Canadian financial institution stating its interest to provide up to $200 ...

New York City (New York, United States), May 23, 2025 - Inventiva (Euronext Paris and Nasdaq: IVA) (the "Company"), a clinical-stage biopharmaceutical ...

On January 29, 2025, Inventiva announced the publication in Journal of Hepatology of the results of the investigator-initiated proof-of-concept clinical trial led by Dr. Kenneth Cusi, demonstrating ...

The FDA’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory ...

At CTO West Coast, an expert discussed the implications of the FDA’s expedited approval programmes with a spotlight on ...